UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Hepatic Lipoprotein Export and Remission of Human Type 2 Diabetes after Weight Loss

Cell metabolism, 2020-02, Vol.31 (2), p.233-249.e4

2020

Link zum Volltext

Verfügbarkeit prüfen

Time Course of Normalization of Functional β-Cell Capacity in the Diabetes Remission Clinical Trial After Weight Loss in Type 2 Diabetes

Diabetes care, 2020-04, Vol.43 (4), p.813-820

2020

Link zum Volltext

Verfügbarkeit prüfen

Sex differences in intraorgan fat levels and hepatic lipid metabolism: implications for cardiovascular health and remission of type 2 diabetes after dietary weight loss

Diabetologia, 2022-01, Vol.65 (1), p.226-233

2022

Link zum Volltext

Verfügbarkeit prüfen

312-OR: Gender-Specific Effects on Hepatic Fat Metabolism in Type 2 Diabetes before and after Remission

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Link zum Volltext

Verfügbarkeit prüfen

1781-P: Remission of Type 2 Diabetes over 2 Years Normalizes Morphology of the Whole Pancreas

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Link zum Volltext

Verfügbarkeit prüfen

1844-P: Long-Term Remission of Type 2 Diabetes after Weight Loss Requires Effective Clearance of Hepatic VLDL-TG and Maintenance of Low Intrapancreatic Fat

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Link zum Volltext

Verfügbarkeit prüfen

66-OR: Remission of Type 2 Diabetes for Two Years Is Associated with Full Recovery of Beta-Cell Functional Mass in the Diabetes Remission Clinical Trial (DiRECT)

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Link zum Volltext

Verfügbarkeit prüfen

Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial

The Lancet (British edition), 2018-02, Vol.391 (10120), p.541-551

2018

Link zum Volltext

Verfügbarkeit prüfen

Remission of Human Type 2 Diabetes Requires Decrease in Liver and Pancreas Fat Content but Is Dependent upon Capacity for β Cell Recovery

Cell metabolism, 2018-10, Vol.28 (4), p.547-556.e3

2018

Link zum Volltext

Verfügbarkeit prüfen

Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial

The lancet. Diabetes & endocrinology, 2019-05, Vol.7 (5), p.344-355

2019

Link zum Volltext

Verfügbarkeit prüfen

Change in hepatic output of palmitic acid after weight loss in type 2 diabetes

Journal of hepatology, 2020-08, Vol.73, p.S456

2020

Link zum Volltext

Verfügbarkeit prüfen

FRI116 - Change in hepatic output of palmitic acid after weight loss in type 2 diabetes

Journal of hepatology, 2020-08, Vol.73, p.S456-S456

2020

Link zum Volltext

Verfügbarkeit prüfen

Remission of Human Type 2 Diabetes Requires Decrease in Liver and Pancreas Fat Content but Is Dependent upon Capacity for β Cell Recovery

Cell metabolism, 2018-10, Vol.28 (4), p.667-667

2018

Link zum Volltext

Verfügbarkeit prüfen

The Natural History of Subclinical Hyperthyroidism in Graves' Disease: The Rule of Thirds

Thyroid (New York, N.Y.), 2016-06, Vol.26 (6), p.765

2016

Link zum Volltext

Verfügbarkeit prüfen

Participant experiences in the Diabetes REmission Clinical Trial (DiRECT)

Diabetic medicine, 2022-01, Vol.39 (1), p.e14689-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Physical activity, inactivity and sleep during the Diabetes Remission Clinical Trial (DiRECT)

Diabetic medicine, 2023-03, Vol.40 (3), p.e15010-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Weight loss‐induced increase in fasting ghrelin concentration is a predictor of weight regain: Evidence from the Diabetes Remission Clinical Trial (DiRECT)

Diabetes, obesity & metabolism, 2021-03, Vol.23 (3), p.711-719

2021

Link zum Volltext

Verfügbarkeit prüfen

Weight loss-induced increase in fasting ghrelin concentration is a predictor of weight regain: Evidence from the Diabetes Remission Clinical Trial (DiRECT)

Diabetes, obesity & metabolism, 2021-03

2021

Link zum Volltext

Verfügbarkeit prüfen

5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study

The lancet. Diabetes & endocrinology, 2024-04, Vol.12 (4), p.233-246

2024

Link zum Volltext

Verfügbarkeit prüfen

Diabetes Remission Clinical Trial (DiRECT)—Plasma Liver Function Tests Reflect Change in Liver Fat Content in Early Type 2 Diabetes

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Link zum Volltext

Verfügbarkeit prüfen

Diabetes Remission Clinical Trial (DiRECT)—Changes in Hepatic VLDL1-TG Production and Intrapancreatic Fat during Weight Maintenance Phase

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Link zum Volltext

Verfügbarkeit prüfen

Pathophysiology of Remission in Type 2 Diabetes—The Diabetes Remission Clinical Trial (DiRECT)

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Link zum Volltext

Verfügbarkeit prüfen

The Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial

BMC family practice, 2016-02, Vol.17, p.20

2016

Link zum Volltext

Verfügbarkeit prüfen

Obesity and Type 2 Diabetes

Obesity, 2019, p.195-226

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(24)
Buchkapitel
(1)

Sprache

Englisch
(25)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Diabetes
(7)
Cell Metabolism
(3)
Diabetes, Obesity & Metabolism
(2)
Diabetic Medicine
(2)
Diabetologia
(2)
Journal Of Hepatology
(2)
The Lancet. Diabetes & Endocrinology
(2)
Bmc Family Practice
(1)
Diabetes Care
(1)
The Lancet
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Hepatic Lipoprotein Export and Remission of Human Type 2 Diabetes after Weight Loss

Time Course of Normalization of Functional β-Cell Capacity in the Diabetes Remission Clinical Trial After Weight Loss in Type 2 Diabetes

Sex differences in intraorgan fat levels and hepatic lipid metabolism: implications for cardiovascular health and remission of type 2 diabetes after dietary weight loss

312-OR: Gender-Specific Effects on Hepatic Fat Metabolism in Type 2 Diabetes before and after Remission

1781-P: Remission of Type 2 Diabetes over 2 Years Normalizes Morphology of the Whole Pancreas

1844-P: Long-Term Remission of Type 2 Diabetes after Weight Loss Requires Effective Clearance of Hepatic VLDL-TG and Maintenance of Low Intrapancreatic Fat

66-OR: Remission of Type 2 Diabetes for Two Years Is Associated with Full Recovery of Beta-Cell Functional Mass in the Diabetes Remission Clinical Trial (DiRECT)

Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial

Remission of Human Type 2 Diabetes Requires Decrease in Liver and Pancreas Fat Content but Is Dependent upon Capacity for β Cell Recovery

Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial

Change in hepatic output of palmitic acid after weight loss in type 2 diabetes

FRI116 - Change in hepatic output of palmitic acid after weight loss in type 2 diabetes

Remission of Human Type 2 Diabetes Requires Decrease in Liver and Pancreas Fat Content but Is Dependent upon Capacity for β Cell Recovery

The Natural History of Subclinical Hyperthyroidism in Graves' Disease: The Rule of Thirds

Participant experiences in the Diabetes REmission Clinical Trial (DiRECT)

Physical activity, inactivity and sleep during the Diabetes Remission Clinical Trial (DiRECT)

Weight loss‐induced increase in fasting ghrelin concentration is a predictor of weight regain: Evidence from the Diabetes Remission Clinical Trial (DiRECT)

Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohort

Weight loss-induced increase in fasting ghrelin concentration is a predictor of weight regain: Evidence from the Diabetes Remission Clinical Trial (DiRECT)

5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study

Diabetes Remission Clinical Trial (DiRECT)—Plasma Liver Function Tests Reflect Change in Liver Fat Content in Early Type 2 Diabetes

Diabetes Remission Clinical Trial (DiRECT)—Changes in Hepatic VLDL1-TG Production and Intrapancreatic Fat during Weight Maintenance Phase

Pathophysiology of Remission in Type 2 Diabetes—The Diabetes Remission Clinical Trial (DiRECT)

The Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial

Obesity and Type 2 Diabetes

Suchergebnisse filtern